nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—AKT1—meningioma	0.827	1	CbGaD
Arsenic trioxide—MAPK1—brainstem—meningioma	0.00138	0.0641	CbGeAlD
Arsenic trioxide—AKT1—brainstem—meningioma	0.00115	0.0535	CbGeAlD
Arsenic trioxide—CCND1—medulla oblongata—meningioma	0.00114	0.0531	CbGeAlD
Arsenic trioxide—CCND1—spinal cord—meningioma	0.00102	0.0473	CbGeAlD
Arsenic trioxide—JUN—brainstem—meningioma	0.001	0.0466	CbGeAlD
Arsenic trioxide—TXNRD1—medulla oblongata—meningioma	0.000896	0.0416	CbGeAlD
Arsenic trioxide—MAPK1—spinal cord—meningioma	0.000858	0.0399	CbGeAlD
Arsenic trioxide—MAPK3—medulla oblongata—meningioma	0.000852	0.0396	CbGeAlD
Arsenic trioxide—CCND1—cerebellum—meningioma	0.000808	0.0375	CbGeAlD
Arsenic trioxide—AKT1—medulla oblongata—meningioma	0.000803	0.0373	CbGeAlD
Arsenic trioxide—TXNRD1—spinal cord—meningioma	0.000799	0.0371	CbGeAlD
Arsenic trioxide—MAPK3—spinal cord—meningioma	0.00076	0.0353	CbGeAlD
Arsenic trioxide—AKT1—spinal cord—meningioma	0.000716	0.0333	CbGeAlD
Arsenic trioxide—JUN—medulla oblongata—meningioma	0.000699	0.0325	CbGeAlD
Arsenic trioxide—MAPK1—cerebellum—meningioma	0.00068	0.0316	CbGeAlD
Arsenic trioxide—CCND1—brain—meningioma	0.000656	0.0305	CbGeAlD
Arsenic trioxide—TXNRD1—cerebellum—meningioma	0.000633	0.0294	CbGeAlD
Arsenic trioxide—JUN—spinal cord—meningioma	0.000623	0.029	CbGeAlD
Arsenic trioxide—MAPK3—cerebellum—meningioma	0.000602	0.028	CbGeAlD
Arsenic trioxide—AKT1—cerebellum—meningioma	0.000568	0.0264	CbGeAlD
Arsenic trioxide—MAPK1—brain—meningioma	0.000553	0.0257	CbGeAlD
Arsenic trioxide—TXNRD1—brain—meningioma	0.000514	0.0239	CbGeAlD
Arsenic trioxide—JUN—cerebellum—meningioma	0.000494	0.023	CbGeAlD
Arsenic trioxide—IKBKB—cerebellum—meningioma	0.000492	0.0229	CbGeAlD
Arsenic trioxide—MAPK3—brain—meningioma	0.000489	0.0227	CbGeAlD
Arsenic trioxide—AKT1—brain—meningioma	0.000461	0.0214	CbGeAlD
Arsenic trioxide—JUN—brain—meningioma	0.000402	0.0187	CbGeAlD
Arsenic trioxide—IKBKB—brain—meningioma	0.0004	0.0186	CbGeAlD
Arsenic trioxide—CYP1B1—cerebellum—meningioma	0.000264	0.0122	CbGeAlD
Arsenic trioxide—CYP1B1—brain—meningioma	0.000214	0.00995	CbGeAlD
Arsenic trioxide—CYP1A1—brain—meningioma	0.000151	0.00703	CbGeAlD
Arsenic trioxide—ABCB1—medulla oblongata—meningioma	0.000137	0.00636	CbGeAlD
Arsenic trioxide—ABCB1—spinal cord—meningioma	0.000122	0.00567	CbGeAlD
Arsenic trioxide—ABCB1—cerebellum—meningioma	9.68e-05	0.0045	CbGeAlD
Arsenic trioxide—ABCB1—brain—meningioma	7.86e-05	0.00365	CbGeAlD
Arsenic trioxide—JUN—MAPK Signaling Pathway—TP53—meningioma	5.31e-05	0.00035	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—ERBB2—meningioma	5.28e-05	0.000348	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—PLAU—meningioma	5.25e-05	0.000346	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—PDGFB—meningioma	5.25e-05	0.000346	CbGpPWpGaD
Arsenic trioxide—JUN—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	5.22e-05	0.000344	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—CST3—meningioma	5.2e-05	0.000343	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—TP53—meningioma	5.13e-05	0.000338	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—SMO—meningioma	5.11e-05	0.000337	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—TP53—meningioma	5.1e-05	0.000336	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—PLAU—meningioma	5.09e-05	0.000336	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—PDGFB—meningioma	5.07e-05	0.000334	CbGpPWpGaD
Arsenic trioxide—JUN—BDNF signaling pathway—AKT1—meningioma	5.07e-05	0.000334	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—ERBB2—meningioma	5.05e-05	0.000333	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—CST3—meningioma	5.05e-05	0.000333	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—ERBB2—meningioma	5.02e-05	0.000331	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—PDGFB—meningioma	4.99e-05	0.000329	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—TP53—meningioma	4.95e-05	0.000326	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular Senescence—TP53—meningioma	4.89e-05	0.000322	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by NGF—PTEN—meningioma	4.88e-05	0.000322	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Breast Cancer Pathway—AKT1—meningioma	4.88e-05	0.000322	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—PDGFB—meningioma	4.87e-05	0.000321	CbGpPWpGaD
Arsenic trioxide—MAPK3—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	4.86e-05	0.00032	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—PLAU—meningioma	4.85e-05	0.000319	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—PGR—meningioma	4.83e-05	0.000318	CbGpPWpGaD
Arsenic trioxide—MAPK1—TGF-beta Signaling Pathway—AKT1—meningioma	4.82e-05	0.000318	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by SCF-KIT—AKT1—meningioma	4.8e-05	0.000317	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—CST3—meningioma	4.8e-05	0.000317	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—TP53—meningioma	4.79e-05	0.000316	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—ERBB2—meningioma	4.78e-05	0.000315	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—PTEN—meningioma	4.73e-05	0.000312	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—PDGFB—meningioma	4.72e-05	0.000311	CbGpPWpGaD
Arsenic trioxide—MAPK3—BDNF signaling pathway—AKT1—meningioma	4.72e-05	0.000311	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—TP53—meningioma	4.71e-05	0.00031	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—PGR—meningioma	4.68e-05	0.000308	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—PDGFB—meningioma	4.68e-05	0.000308	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—HES1—meningioma	4.67e-05	0.000308	CbGpPWpGaD
Arsenic trioxide—JUN—Insulin Signaling—AKT1—meningioma	4.66e-05	0.000307	CbGpPWpGaD
Arsenic trioxide—MAPK1—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	4.62e-05	0.000305	CbGpPWpGaD
Arsenic trioxide—JUN—EGF/EGFR Signaling Pathway—AKT1—meningioma	4.61e-05	0.000304	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—TSHB—meningioma	4.6e-05	0.000303	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	4.6e-05	0.000303	CbGpPWpGaD
Arsenic trioxide—JUN—Circadian rythm related genes—TP53—meningioma	4.6e-05	0.000303	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signaling of activated FGFR—AKT1—meningioma	4.6e-05	0.000303	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by SCF-KIT—AKT1—meningioma	4.57e-05	0.000301	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular Senescence—TP53—meningioma	4.56e-05	0.0003	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by ERBB4—AKT1—meningioma	4.52e-05	0.000298	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—PTEN—meningioma	4.51e-05	0.000297	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—TP53—meningioma	4.5e-05	0.000297	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—PDGFB—meningioma	4.5e-05	0.000296	CbGpPWpGaD
Arsenic trioxide—MAPK1—BDNF signaling pathway—AKT1—meningioma	4.5e-05	0.000296	CbGpPWpGaD
Arsenic trioxide—JUN—MAPK Signaling Pathway—AKT1—meningioma	4.48e-05	0.000295	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—meningioma	4.46e-05	0.000294	CbGpPWpGaD
Arsenic trioxide—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	4.42e-05	0.000292	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signaling of activated FGFR—AKT1—meningioma	4.37e-05	0.000288	CbGpPWpGaD
Arsenic trioxide—MAPK3—Insulin Signaling—AKT1—meningioma	4.34e-05	0.000286	CbGpPWpGaD
Arsenic trioxide—CCND1—Cell Cycle—TP53—meningioma	4.34e-05	0.000286	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular Senescence—TP53—meningioma	4.34e-05	0.000286	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Breast Cancer Pathway—AKT1—meningioma	4.33e-05	0.000285	CbGpPWpGaD
Arsenic trioxide—MAPK3—Downstream signal transduction—AKT1—meningioma	4.32e-05	0.000285	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—PTEN—meningioma	4.31e-05	0.000284	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB4—AKT1—meningioma	4.31e-05	0.000284	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—PDGFB—meningioma	4.3e-05	0.000283	CbGpPWpGaD
Arsenic trioxide—IKBKB—BDNF signaling pathway—AKT1—meningioma	4.3e-05	0.000283	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR—AKT1—meningioma	4.3e-05	0.000283	CbGpPWpGaD
Arsenic trioxide—JUN—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	4.3e-05	0.000283	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by ERBB2—AKT1—meningioma	4.28e-05	0.000282	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 signaling—AKT1—meningioma	4.26e-05	0.000281	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	4.25e-05	0.00028	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—AKT1—meningioma	4.18e-05	0.000275	CbGpPWpGaD
Arsenic trioxide—MAPK1—Insulin Signaling—AKT1—meningioma	4.13e-05	0.000272	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—PDGFB—meningioma	4.13e-05	0.000272	CbGpPWpGaD
Arsenic trioxide—MAPK1—Downstream signal transduction—AKT1—meningioma	4.11e-05	0.000271	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR—AKT1—meningioma	4.09e-05	0.00027	CbGpPWpGaD
Arsenic trioxide—MAPK1—EGF/EGFR Signaling Pathway—AKT1—meningioma	4.09e-05	0.00027	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by ERBB2—AKT1—meningioma	4.07e-05	0.000268	CbGpPWpGaD
Arsenic trioxide—JUN—Focal Adhesion—AKT1—meningioma	4.06e-05	0.000268	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 signaling—AKT1—meningioma	4.05e-05	0.000267	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	4.04e-05	0.000267	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TSHB—meningioma	4.01e-05	0.000264	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by FGFR in disease—AKT1—meningioma	4.01e-05	0.000264	CbGpPWpGaD
Arsenic trioxide—MAPK3—DAP12 interactions—AKT1—meningioma	4.01e-05	0.000264	CbGpPWpGaD
Arsenic trioxide—MAPK3—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	4.01e-05	0.000264	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—PDGFB—meningioma	4e-05	0.000263	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—AKT1—meningioma	3.97e-05	0.000262	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR—AKT1—meningioma	3.97e-05	0.000262	CbGpPWpGaD
Arsenic trioxide—IKBKB—Insulin Signaling—AKT1—meningioma	3.95e-05	0.000261	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by EGFR in Cancer—AKT1—meningioma	3.93e-05	0.000259	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by PDGF—AKT1—meningioma	3.92e-05	0.000258	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TSHB—meningioma	3.85e-05	0.000254	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—TSHB—meningioma	3.83e-05	0.000252	CbGpPWpGaD
Arsenic trioxide—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	3.82e-05	0.000252	CbGpPWpGaD
Arsenic trioxide—MAPK1—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	3.81e-05	0.000251	CbGpPWpGaD
Arsenic trioxide—MAPK1—DAP12 interactions—AKT1—meningioma	3.81e-05	0.000251	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by FGFR in disease—AKT1—meningioma	3.81e-05	0.000251	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—AKT1—meningioma	3.8e-05	0.000251	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR—AKT1—meningioma	3.78e-05	0.000249	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	3.77e-05	0.000248	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by EGFR in Cancer—AKT1—meningioma	3.74e-05	0.000247	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TSHB—meningioma	3.73e-05	0.000246	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by PDGF—AKT1—meningioma	3.73e-05	0.000246	CbGpPWpGaD
Arsenic trioxide—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	3.72e-05	0.000245	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—ERBB2—meningioma	3.7e-05	0.000244	CbGpPWpGaD
Arsenic trioxide—JUN—Cellular responses to stress—TP53—meningioma	3.7e-05	0.000244	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—PTEN—meningioma	3.66e-05	0.000241	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ALAD—meningioma	3.66e-05	0.000241	CbGpPWpGaD
Arsenic trioxide—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	3.65e-05	0.00024	CbGpPWpGaD
Arsenic trioxide—MAPK1—Focal Adhesion—AKT1—meningioma	3.6e-05	0.000237	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	3.59e-05	0.000236	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—ERBB2—meningioma	3.59e-05	0.000236	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TSHB—meningioma	3.55e-05	0.000234	CbGpPWpGaD
Arsenic trioxide—MAPK3—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	3.55e-05	0.000234	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cellular responses to stress—TP53—meningioma	3.45e-05	0.000227	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—ERBB2—meningioma	3.41e-05	0.000225	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SMO—meningioma	3.41e-05	0.000224	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—ERBB2—meningioma	3.4e-05	0.000224	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TSHB—meningioma	3.4e-05	0.000224	CbGpPWpGaD
Arsenic trioxide—MAPK1—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	3.38e-05	0.000222	CbGpPWpGaD
Arsenic trioxide—IKBKB—B Cell Activation—AKT1—meningioma	3.37e-05	0.000222	CbGpPWpGaD
Arsenic trioxide—MAPK3—Platelet activation, signaling and aggregation—AKT1—meningioma	3.35e-05	0.000221	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cellular responses to stress—TP53—meningioma	3.28e-05	0.000216	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SMO—meningioma	3.27e-05	0.000216	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PGR—meningioma	3.27e-05	0.000215	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—ERBB2—meningioma	3.27e-05	0.000215	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	3.23e-05	0.000213	CbGpPWpGaD
Arsenic trioxide—MAPK1—Platelet activation, signaling and aggregation—AKT1—meningioma	3.19e-05	0.00021	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SMO—meningioma	3.17e-05	0.000209	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—ERBB2—meningioma	3.17e-05	0.000209	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PGR—meningioma	3.14e-05	0.000207	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—ERBB2—meningioma	3.14e-05	0.000207	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—HES1—meningioma	3.06e-05	0.000202	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PGR—meningioma	3.04e-05	0.000201	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SMO—meningioma	3.02e-05	0.000199	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—ERBB2—meningioma	3.01e-05	0.000199	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—HES1—meningioma	2.97e-05	0.000196	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—PDGFB—meningioma	2.95e-05	0.000195	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ALAD—meningioma	2.92e-05	0.000192	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—PTEN—meningioma	2.9e-05	0.000191	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PGR—meningioma	2.9e-05	0.000191	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SMO—meningioma	2.89e-05	0.00019	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—ERBB2—meningioma	2.88e-05	0.00019	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—PDGFB—meningioma	2.84e-05	0.000187	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—HES1—meningioma	2.83e-05	0.000186	CbGpPWpGaD
Arsenic trioxide—AKT1—Innate Immune System—PTEN—meningioma	2.78e-05	0.000183	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PGR—meningioma	2.77e-05	0.000183	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—ERBB2—meningioma	2.77e-05	0.000182	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	2.76e-05	0.000182	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—PDGFB—meningioma	2.75e-05	0.000181	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by NGF—AKT1—meningioma	2.73e-05	0.00018	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—PTEN—meningioma	2.7e-05	0.000178	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—ERBB2—meningioma	2.68e-05	0.000176	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—PTEN—meningioma	2.67e-05	0.000176	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PDGFB—meningioma	2.62e-05	0.000173	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—PDGFB—meningioma	2.62e-05	0.000173	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by NGF—AKT1—meningioma	2.6e-05	0.000171	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—PTEN—meningioma	2.57e-05	0.000169	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PDGFB—meningioma	2.54e-05	0.000167	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—PDGFB—meningioma	2.51e-05	0.000165	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling by NGF—AKT1—meningioma	2.48e-05	0.000164	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—PTEN—meningioma	2.46e-05	0.000162	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PDGFB—meningioma	2.42e-05	0.000159	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—PTEN—meningioma	2.36e-05	0.000156	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—TSHB—meningioma	2.36e-05	0.000155	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—meningioma	2.34e-05	0.000154	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—PTEN—meningioma	2.28e-05	0.00015	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—HES1—meningioma	2.23e-05	0.000147	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—HES1—meningioma	2.14e-05	0.000141	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TP53—meningioma	2.11e-05	0.000139	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—AKT1—meningioma	2.11e-05	0.000139	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—HES1—meningioma	2.08e-05	0.000137	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TP53—meningioma	2.05e-05	0.000135	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—HES1—meningioma	1.98e-05	0.00013	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—ERBB2—meningioma	1.98e-05	0.00013	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TP53—meningioma	1.95e-05	0.000128	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—TP53—meningioma	1.93e-05	0.000127	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PDGFB—meningioma	1.91e-05	0.000126	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—ERBB2—meningioma	1.9e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—HES1—meningioma	1.89e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—TSHB—meningioma	1.88e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	1.88e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—ERBB2—meningioma	1.84e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—TP53—meningioma	1.84e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PDGFB—meningioma	1.83e-05	0.000121	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALAD—meningioma	1.8e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PDGFB—meningioma	1.78e-05	0.000117	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—AKT1—meningioma	1.76e-05	0.000116	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—ERBB2—meningioma	1.76e-05	0.000116	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—ERBB2—meningioma	1.76e-05	0.000116	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—AKT1—meningioma	1.73e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—ERBB2—meningioma	1.7e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PDGFB—meningioma	1.69e-05	0.000112	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—PTEN—meningioma	1.69e-05	0.000111	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—ERBB2—meningioma	1.68e-05	0.000111	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—AKT1—meningioma	1.68e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—JUN—Innate Immune System—AKT1—meningioma	1.67e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—AKT1—meningioma	1.64e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—PTEN—meningioma	1.62e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—ERBB2—meningioma	1.62e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PDGFB—meningioma	1.62e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	1.59e-05	0.000105	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—PTEN—meningioma	1.57e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TP53—meningioma	1.56e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—MAPK3—Innate Immune System—AKT1—meningioma	1.56e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—PTEN—meningioma	1.5e-05	9.87e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—PTEN—meningioma	1.5e-05	9.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Innate Immune System—AKT1—meningioma	1.48e-05	9.76e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—PTEN—meningioma	1.45e-05	9.57e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—meningioma	1.44e-05	9.5e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—PTEN—meningioma	1.43e-05	9.44e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Innate Immune System—AKT1—meningioma	1.42e-05	9.34e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—PTEN—meningioma	1.38e-05	9.11e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—AKT1—meningioma	1.36e-05	8.97e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—AKT1—meningioma	1.32e-05	8.67e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—ERBB2—meningioma	1.28e-05	8.43e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—PTEN—meningioma	1.25e-05	8.26e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—ERBB2—meningioma	1.23e-05	8.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—ERBB2—meningioma	1.19e-05	7.86e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—TSHB—meningioma	1.16e-05	7.64e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—ERBB2—meningioma	1.13e-05	7.48e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—PTEN—meningioma	1.09e-05	7.19e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—ERBB2—meningioma	1.09e-05	7.15e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—PTEN—meningioma	1.05e-05	6.91e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—PTEN—meningioma	1.04e-05	6.87e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—PTEN—meningioma	1.02e-05	6.7e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AKT1—meningioma	9.92e-06	6.54e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—AKT1—meningioma	9.73e-06	6.41e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—PTEN—meningioma	9.68e-06	6.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AKT1—meningioma	9.44e-06	6.22e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—PTEN—meningioma	9.26e-06	6.1e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—AKT1—meningioma	9.06e-06	5.97e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—AKT1—meningioma	9.01e-06	5.94e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—AKT1—meningioma	8.63e-06	5.68e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—AKT1—meningioma	8.37e-06	5.52e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—AKT1—meningioma	8.25e-06	5.44e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—AKT1—meningioma	7.96e-06	5.25e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TP53—meningioma	7.45e-06	4.91e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TP53—meningioma	7.16e-06	4.72e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TP53—meningioma	6.94e-06	4.57e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TP53—meningioma	6.6e-06	4.35e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—PTEN—meningioma	6.42e-06	4.23e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TP53—meningioma	6.32e-06	4.16e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AKT1—meningioma	6.29e-06	4.14e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—AKT1—meningioma	6.01e-06	3.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AKT1—meningioma	5.86e-06	3.86e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AKT1—meningioma	5.58e-06	3.67e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AKT1—meningioma	5.34e-06	3.52e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—PTEN—meningioma	5.13e-06	3.38e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AKT1—meningioma	3.7e-06	2.44e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—PTEN—meningioma	3.16e-06	2.08e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AKT1—meningioma	2.95e-06	1.95e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AKT1—meningioma	1.82e-06	1.2e-05	CbGpPWpGaD
